2025-10-30
Repurgenesis x Altos Computing: Empowering AI-Driven Drug Discovery
About Repurgenesis
Repurgenesis is a cutting-edge company focused on accelerating drug development through AI-powered technologies and platforms, with a strategic emphasis on drug repurposing for rapid commercialization.
Our platform is an intelligent, orchestral drug repurposing system integrating multiple data types, modalities, methodologies, and AI algorithms to enhance the precision and efficiency of drug discovery.
The Collaboration
Through this partnership, Repurgenesis combines its advanced biomedical AI expertise with Altos' high-performance computing (HPC) infrastructure and AI orchestration platform, Altos aiWorks, to build a next-generation intelligent drug development platform.
This collaboration represents a major milestone in bridging AI innovation and biomedical research, reinforcing both companies’ commitment to advancing global healthcare through technology and scientific collaboration.
https://news.gbimonthly.com/tw/invest/show.php?num=81158
Repurgenesis is a cutting-edge company focused on accelerating drug development through AI-powered technologies and platforms, with a strategic emphasis on drug repurposing for rapid commercialization.
Our platform is an intelligent, orchestral drug repurposing system integrating multiple data types, modalities, methodologies, and AI algorithms to enhance the precision and efficiency of drug discovery.
The Collaboration
Through this partnership, Repurgenesis combines its advanced biomedical AI expertise with Altos' high-performance computing (HPC) infrastructure and AI orchestration platform, Altos aiWorks, to build a next-generation intelligent drug development platform.
This collaboration represents a major milestone in bridging AI innovation and biomedical research, reinforcing both companies’ commitment to advancing global healthcare through technology and scientific collaboration.
https://news.gbimonthly.com/tw/invest/show.php?num=81158